TP53 and lung carcinoma: Targeting the P2 site with gRNA and utilizing dcas9 antibody immunoprecipitation against three lung cancer cell lines, specific bands for 120KD were observed in mutant TP53 cell lines relative to A549 (Fig. 2D).